Logo image of SYP.DE

SYNOPSYS INC (SYP.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:SYP - US8716071076 - Common Stock

450 EUR
+10.05 (+2.28%)
Last: 1/9/2026, 7:00:00 PM
Fundamental Rating

4

Overall SYP gets a fundamental rating of 4 out of 10. We evaluated SYP against 114 industry peers in the Software industry. SYP scores excellent on profitability, but there are concerns on its financial health. SYP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year SYP was profitable.
SYP had a positive operating cash flow in the past year.
SYP had positive earnings in each of the past 5 years.
SYP had a positive operating cash flow in each of the past 5 years.
SYP.DE Yearly Net Income VS EBIT VS OCF VS FCFSYP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5B -10B -15B

1.2 Ratios

The Return On Assets of SYP (4.14%) is comparable to the rest of the industry.
With a Return On Equity value of 7.23%, SYP perfoms like the industry average, outperforming 50.88% of the companies in the same industry.
SYP has a Return On Invested Capital (1.74%) which is in line with its industry peers.
SYP had an Average Return On Invested Capital over the past 3 years of 11.39%. This is in line with the industry average of 12.49%.
The 3 year average ROIC (11.39%) for SYP is well above the current ROIC(1.74%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 4.14%
ROE 7.23%
ROIC 1.74%
ROA(3y)13.22%
ROA(5y)11.32%
ROE(3y)21.01%
ROE(5y)18.18%
ROIC(3y)11.39%
ROIC(5y)10.05%
SYP.DE Yearly ROA, ROE, ROICSYP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

SYP has a better Profit Margin (31.04%) than 91.23% of its industry peers.
In the last couple of years the Profit Margin of SYP has grown nicely.
With a decent Operating Margin value of 17.16%, SYP is doing good in the industry, outperforming 70.18% of the companies in the same industry.
SYP's Operating Margin has improved in the last couple of years.
SYP's Gross Margin of 79.12% is fine compared to the rest of the industry. SYP outperforms 64.91% of its industry peers.
In the last couple of years the Gross Margin of SYP has remained more or less at the same level.
Industry RankSector Rank
OM 17.16%
PM (TTM) 31.04%
GM 79.12%
OM growth 3Y6.59%
OM growth 5Y6.25%
PM growth 3Y27.03%
PM growth 5Y18.45%
GM growth 3Y0.07%
GM growth 5Y0.53%
SYP.DE Yearly Profit, Operating, Gross MarginsSYP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SYP is still creating some value.
SYP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SYP has been increased compared to 5 years ago.
The debt/assets ratio for SYP is higher compared to a year ago.
SYP.DE Yearly Shares OutstandingSYP.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
SYP.DE Yearly Total Debt VS Total AssetsSYP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 3.40 indicates that SYP is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 3.40, SYP perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
SYP has a Debt/Equity ratio of 0.52. This is a neutral value indicating SYP is somewhat dependend on debt financing.
SYP has a Debt to Equity ratio of 0.52. This is in the lower half of the industry: SYP underperforms 64.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z 3.4
ROIC/WACC0.16
WACC10.96%
SYP.DE Yearly LT Debt VS Equity VS FCFSYP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B

2.3 Liquidity

A Current Ratio of 1.62 indicates that SYP should not have too much problems paying its short term obligations.
SYP's Current ratio of 1.62 is fine compared to the rest of the industry. SYP outperforms 60.53% of its industry peers.
SYP has a Quick Ratio of 1.51. This is a normal value and indicates that SYP is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.51, SYP perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.51
SYP.DE Yearly Current Assets VS Current LiabilitesSYP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

3

3. Growth

3.1 Past

SYP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.67%.
The Earnings Per Share has been growing by 18.54% on average over the past years. This is quite good.
EPS 1Y (TTM)-1.67%
EPS 3Y13.39%
EPS 5Y18.54%
EPS Q2Q%-14.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%37.83%

3.2 Future

SYP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.84% yearly.
The Revenue is expected to grow by 15.94% on average over the next years. This is quite good.
EPS Next Y12.9%
EPS Next 2Y15.44%
EPS Next 3Y16.32%
EPS Next 5Y15.84%
Revenue Next Year36.7%
Revenue Next 2Y23.08%
Revenue Next 3Y19.01%
Revenue Next 5Y15.94%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SYP.DE Yearly Revenue VS EstimatesSYP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
SYP.DE Yearly EPS VS EstimatesSYP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 40.43 indicates a quite expensive valuation of SYP.
The rest of the industry has a similar Price/Earnings ratio as SYP.
When comparing the Price/Earnings ratio of SYP to the average of the S&P500 Index (27.19), we can say SYP is valued slightly more expensively.
SYP is valuated quite expensively with a Price/Forward Earnings ratio of 35.82.
The rest of the industry has a similar Price/Forward Earnings ratio as SYP.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.88, SYP is valued quite expensively.
Industry RankSector Rank
PE 40.43
Fwd PE 35.82
SYP.DE Price Earnings VS Forward Price EarningsSYP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

64.91% of the companies in the same industry are cheaper than SYP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 76.59
SYP.DE Per share dataSYP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SYP does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SYP may justify a higher PE ratio.
A more expensive valuation may be justified as SYP's earnings are expected to grow with 16.32% in the coming years.
PEG (NY)3.13
PEG (5Y)2.18
EPS Next 2Y15.44%
EPS Next 3Y16.32%

0

5. Dividend

5.1 Amount

SYP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SYNOPSYS INC

FRA:SYP (1/9/2026, 7:00:00 PM)

450

+10.05 (+2.28%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-10 2025-12-10/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners93.54%
Inst Owner ChangeN/A
Ins Owners0.41%
Ins Owner ChangeN/A
Market Cap85.76B
Revenue(TTM)N/A
Net Income(TTM)2.00B
Analysts81.29
Price Target486.13 (8.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.32%
Min EPS beat(2)-10.9%
Max EPS beat(2)6.25%
EPS beat(4)3
Avg EPS beat(4)0.22%
Min EPS beat(4)-10.9%
Max EPS beat(4)6.25%
EPS beat(8)5
Avg EPS beat(8)0.24%
EPS beat(12)9
Avg EPS beat(12)0.86%
EPS beat(16)12
Avg EPS beat(16)1.03%
Revenue beat(2)0
Avg Revenue beat(2)-2.57%
Min Revenue beat(2)-3.51%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-2.36%
Min Revenue beat(4)-3.51%
Max Revenue beat(4)-1.62%
Revenue beat(8)0
Avg Revenue beat(8)-2.19%
Revenue beat(12)0
Avg Revenue beat(12)-5.73%
Revenue beat(16)0
Avg Revenue beat(16)-4.55%
PT rev (1m)-1.85%
PT rev (3m)-0.14%
EPS NQ rev (1m)0.01%
EPS NQ rev (3m)0.04%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)-3.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 40.43
Fwd PE 35.82
P/S 15.56
P/FCF N/A
P/OCF 69.45
P/B 3.63
P/tB N/A
EV/EBITDA 76.59
EPS(TTM)11.13
EY2.47%
EPS(NY)12.56
Fwd EY2.79%
FCF(TTM)-69.12
FCFYN/A
OCF(TTM)6.48
OCFY1.44%
SpS28.92
BVpS124.12
TBVpS-55.78
PEG (NY)3.13
PEG (5Y)2.18
Graham Number176.3
Profitability
Industry RankSector Rank
ROA 4.14%
ROE 7.23%
ROCE 2.47%
ROIC 1.74%
ROICexc 1.84%
ROICexgc 35.88%
OM 17.16%
PM (TTM) 31.04%
GM 79.12%
FCFM N/A
ROA(3y)13.22%
ROA(5y)11.32%
ROE(3y)21.01%
ROE(5y)18.18%
ROIC(3y)11.39%
ROIC(5y)10.05%
ROICexc(3y)15.76%
ROICexc(5y)13.64%
ROICexgc(3y)67.42%
ROICexgc(5y)61.02%
ROCE(3y)16.17%
ROCE(5y)14.27%
ROICexgc growth 3Y-16.41%
ROICexgc growth 5Y-15.59%
ROICexc growth 3Y9.63%
ROICexc growth 5Y8.74%
OM growth 3Y6.59%
OM growth 5Y6.25%
PM growth 3Y27.03%
PM growth 5Y18.45%
GM growth 3Y0.07%
GM growth 5Y0.53%
F-Score2
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA 10.01
Cap/Depr 5156.15%
Cap/Sales 261.38%
Interest Coverage 250
Cash Conversion 100.78%
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.51
Altman-Z 3.4
F-Score2
WACC10.96%
ROIC/WACC0.16
Cap/Depr(3y)179.61%
Cap/Depr(5y)180.51%
Cap/Sales(3y)8.65%
Cap/Sales(5y)9%
Profit Quality(3y)89.35%
Profit Quality(5y)101.69%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.67%
EPS 3Y13.39%
EPS 5Y18.54%
EPS Q2Q%-14.71%
EPS Next Y12.9%
EPS Next 2Y15.44%
EPS Next 3Y16.32%
EPS Next 5Y15.84%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%37.83%
Revenue Next Year36.7%
Revenue Next 2Y23.08%
Revenue Next 3Y19.01%
Revenue Next 5Y15.94%
EBIT growth 1Y-24.76%
EBIT growth 3Y20.85%
EBIT growth 5Y19.81%
EBIT Next Year23.73%
EBIT Next 3Y31.33%
EBIT Next 5Y24.99%
FCF growth 1Y-1098.34%
FCF growth 3Y0.78%
FCF growth 5Y14.95%
OCF growth 1Y-18.58%
OCF growth 3Y-1.95%
OCF growth 5Y11.94%

SYNOPSYS INC / SYP.DE FAQ

What is the ChartMill fundamental rating of SYNOPSYS INC (SYP.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SYP.DE.


What is the valuation status for SYP stock?

ChartMill assigns a valuation rating of 1 / 10 to SYNOPSYS INC (SYP.DE). This can be considered as Overvalued.


How profitable is SYNOPSYS INC (SYP.DE) stock?

SYNOPSYS INC (SYP.DE) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for SYP stock?

The Price/Earnings (PE) ratio for SYNOPSYS INC (SYP.DE) is 40.43 and the Price/Book (PB) ratio is 3.63.


How financially healthy is SYNOPSYS INC?

The financial health rating of SYNOPSYS INC (SYP.DE) is 4 / 10.